137 related articles for article (PubMed ID: 1828579)
1. [Infectious risks in patients with renal failure on hemodialysis. Importance of iron overload and deferoxamine].
Hoen B; Kessler M
Presse Med; 1991 Apr; 20(15):681-2. PubMed ID: 1828579
[No Abstract] [Full Text] [Related]
2. The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients.
Boelaert JR; van Landuyt HW; Valcke YJ; Cantinieaux B; Lornoy WF; Vanherweghem JL; Moreillon P; Vandepitte JM
J Infect Dis; 1987 Aug; 156(2):384-7. PubMed ID: 3598237
[No Abstract] [Full Text] [Related]
3. Serum bactericidal activity for Yersinia enterocolitica in hemodialysis patients: effects of iron overload and deferoxamine.
Gaughan WJ; Beserab A; Stein HD; Sirota RA; Yudis M
Am J Kidney Dis; 1992 Feb; 19(2):144-8. PubMed ID: 1739096
[TBL] [Abstract][Full Text] [Related]
4. [Severe Yersinia enterocolitica infections in kidney failure patients under dialysis].
Cabanne JF; Dubot P
Presse Med; 1991 Nov; 20(38):1905. PubMed ID: 1836634
[No Abstract] [Full Text] [Related]
5. [Yersinia enterocolitica septicemia, iron overload and deferoxamine].
Paitel JF; Guerci AP; Dorvaux V; Lederlin P
Rev Med Interne; 1995; 16(9):705-7. PubMed ID: 7481160
[TBL] [Abstract][Full Text] [Related]
6. Septicemia due to Yersinia enterocolitica in a long-term hemodialysis patient after a single desferrioxamine administration.
Hoen B; Renoult E; Jonon B; Kessler M
Nephron; 1988; 50(4):378-9. PubMed ID: 3237280
[TBL] [Abstract][Full Text] [Related]
7. What's in that pork? We found antibiotic-resistant bacteria--and traces of a veterinary drug.
Consum Rep; 2013 Jan; 78(1):44-6. PubMed ID: 23556188
[No Abstract] [Full Text] [Related]
8. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.
Seifert A; von Herrath D; Schaefer K
Q J Med; 1987 Dec; 65(248):1015-24. PubMed ID: 3455553
[TBL] [Abstract][Full Text] [Related]
9. Systemic Yersinia enterocolitica infection associated with iron overload and deferoxamine therapy.
Abcarian PW; Demas BE
AJR Am J Roentgenol; 1991 Oct; 157(4):773-5. PubMed ID: 1892033
[No Abstract] [Full Text] [Related]
10. Food-borne pathogens of recent concern.
Doyle MP
Annu Rev Nutr; 1985; 5():25-41. PubMed ID: 3927947
[No Abstract] [Full Text] [Related]
11. [Desferrioxamine in hemodialysis as the cause of Yersinia enterocolitica septicemia].
Waterlot Y; Vanherweghem JL
Presse Med; 1985 Mar; 14(12):699. PubMed ID: 3157972
[No Abstract] [Full Text] [Related]
12. Effect of aggressively driven intravenous iron therapy on infectious complications in end-stage renal disease patients on maintenance hemodialysis.
Bansal A; Sandhu G; Gupta I; Kalahalli S; Nayak R; Zouain E; Chitale RA; Meisels I; Chan G
Am J Ther; 2014; 21(4):250-3. PubMed ID: 22832501
[TBL] [Abstract][Full Text] [Related]
13. Iron and infection.
Sparling PF
Clin Infect Dis; 1998 Dec; 27(6):1367-8. PubMed ID: 9868643
[No Abstract] [Full Text] [Related]
14. Infection with Yersinia enterocolitica in patients with iron overload.
Chiu HY; Flynn DM; Hoffbrand AV; Politis D
Br Med J (Clin Res Ed); 1986 Jan; 292(6513):97. PubMed ID: 3080107
[No Abstract] [Full Text] [Related]
15. Failure of deferoxamine to improve iron overload in chronic hemodialysis patients.
Roxe DM; Krumlovsky FA; Del Greco F; Fitzsimons E
Int J Artif Organs; 1990 Apr; 13(4):211-7. PubMed ID: 2115505
[TBL] [Abstract][Full Text] [Related]
16. Yersinia sepsis in patients with iron overload treated with deferoxamine.
Gallant T; Freedman MH; Vellend H; Francombe WH
N Engl J Med; 1986 Jun; 314(25):1643. PubMed ID: 3713766
[No Abstract] [Full Text] [Related]
17. Yersiniae and iron intoxication.
Stein ZL; Barkin RL
Drug Intell Clin Pharm; 1987; 21(7-8):661. PubMed ID: 3608819
[No Abstract] [Full Text] [Related]
18. [Hepatic abscess due to Yersinia in a child with thalassemia].
Brunel F; François P; Durand C; Croize J; Jeannoel P
Pediatrie; 1993; 48(2):159-62. PubMed ID: 8393182
[TBL] [Abstract][Full Text] [Related]
19. Effect of deferoxamine therapy on insulin resistance in end-stage renal disease patients with iron overload.
Alnahal AA; Tahan M; Fathy A; Fathy T
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):808-13. PubMed ID: 24969192
[TBL] [Abstract][Full Text] [Related]
20. Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy.
Mazzoleni G; deSa D; Gately J; Riddell RH
Dig Dis Sci; 1991 Aug; 36(8):1154-60. PubMed ID: 1864209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
